Communication Equipment
Compare Stocks
5 / 10Stock Comparison
AMPG vs SIFY vs HCTI vs INFY vs IBM
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Medical - Healthcare Information Services
Information Technology Services
Information Technology Services
AMPG vs SIFY vs HCTI vs INFY vs IBM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Communication Equipment | Telecommunications Services | Medical - Healthcare Information Services | Information Technology Services | Information Technology Services |
| Market Cap | $45M | $1.18B | $48K | $52.03B | $215.52B |
| Revenue (TTM) | $23M | $41.45B | $13M | $19.85B | $68.91B |
| Net Income (TTM) | $-8M | $-1.50B | $-6M | $3.21B | $10.75B |
| Gross Margin | 23.1% | 34.2% | 13.1% | 30.0% | 59.0% |
| Operating Margin | -37.1% | 5.2% | -45.2% | 20.3% | 16.4% |
| Forward P/E | — | — | — | 16.8x | 18.5x |
| Total Debt | $5M | $39.51B | $3M | $962M | $67.15B |
| Cash & Equiv. | $19M | $5.00B | $20K | $2.86B | $13.64B |
AMPG vs SIFY vs HCTI vs INFY vs IBM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| AmpliTech Group, In… (AMPG) | 100 | 57.7 | -42.3% |
| Sify Technologies L… (SIFY) | 100 | 76.5 | -23.5% |
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
| Infosys Limited (INFY) | 100 | 57.6 | -42.4% |
| International Busin… (IBM) | 100 | 192.3 | +92.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMPG vs SIFY vs HCTI vs INFY vs IBM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMPG plays a supporting role in this comparison — it may shine differently against other peers.
SIFY is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 147.9% 10Y total return vs IBM's 108.0%
- 11.9% revenue growth vs HCTI's -64.8%
- +273.9% vs HCTI's -99.9%
HCTI lags the leaders in this set but could rank higher in a more targeted comparison.
INFY carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 4 yrs, beta 0.86, yield 4.5%
- Lower volatility, beta 0.86, Low D/E 8.5%, current ratio 2.27x
- Beta 0.86, yield 4.5%, current ratio 2.27x
- Better valuation composite
IBM is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 7.6%, EPS growth 73.7%, 3Y rev CAGR 3.7%
- PEG 1.49 vs INFY's 2.52
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs HCTI's -64.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 16.2% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.86 vs HCTI's 3.25 | |
| Dividends | 4.5% yield, 4-year raise streak, vs IBM's 2.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +273.9% vs HCTI's -99.9% | |
| Efficiency (ROA) | 18.6% ROA vs HCTI's -60.0%, ROIC 31.8% vs -6.3% |
AMPG vs SIFY vs HCTI vs INFY vs IBM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
AMPG vs SIFY vs HCTI vs INFY vs IBM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INFY leads in 3 of 6 categories
SIFY leads 1 • AMPG leads 0 • HCTI leads 0 • IBM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INFY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IBM is the larger business by revenue, generating $68.9B annually — 5325.0x HCTI's $13M. INFY is the more profitable business, keeping 16.2% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, AMPG holds the edge at +115.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $23M | $41.4B | $13M | $19.8B | $68.9B |
| EBITDAEarnings before interest/tax | -$7M | $8.1B | -$6M | $4.3B | $15.1B |
| Net IncomeAfter-tax profit | -$8M | -$1.5B | -$6M | $3.2B | $10.8B |
| Free Cash FlowCash after capex | -$6M | $0 | -$12M | $3.8B | $13.1B |
| Gross MarginGross profit ÷ Revenue | +23.1% | +34.2% | +13.1% | +30.0% | +59.0% |
| Operating MarginEBIT ÷ Revenue | -37.1% | +5.2% | -45.2% | +20.3% | +16.4% |
| Net MarginNet income ÷ Revenue | -33.8% | -3.6% | -48.9% | +16.2% | +15.6% |
| FCF MarginFCF ÷ Revenue | -26.9% | -9.2% | -94.7% | +19.2% | +19.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +115.0% | +2.5% | +44.6% | +3.2% | +9.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +91.7% | -3.7% | -63.8% | -5.3% | +14.3% |
Valuation Metrics
INFY leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.9x trailing earnings, INFY trades at a 18% valuation discount to IBM's 20.6x P/E. Adjusting for growth (PEG ratio), IBM offers better value at 1.66x vs INFY's 2.53x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45M | $1.2B | $47,905 | $52.0B | $215.5B |
| Enterprise ValueMkt cap + debt − cash | $31M | $1.5B | $3M | $50.1B | $269.0B |
| Trailing P/EPrice ÷ TTM EPS | -2.04x | -122.55x | -0.01x | 16.88x | 20.57x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 16.84x | 18.47x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.53x | 1.66x |
| EV / EBITDAEnterprise value multiple | — | 18.53x | — | 10.80x | 17.53x |
| Price / SalesMarket cap ÷ Revenue | 4.77x | 2.80x | 0.00x | 2.70x | 3.19x |
| Price / BookPrice ÷ Book value/share | 0.61x | 4.77x | — | 4.73x | 6.66x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 12.73x | 18.62x |
Profitability & Efficiency
INFY leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
IBM delivers a 35.4% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-113 for HCTI. INFY carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to IBM's 2.05x. On the Piotroski fundamental quality scale (0–9), INFY scores 5/9 vs HCTI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -21.3% | -7.7% | -112.9% | +29.6% | +35.4% |
| ROA (TTM)Return on assets | -16.1% | -1.8% | -60.0% | +18.6% | +7.1% |
| ROICReturn on invested capital | -27.1% | +3.3% | -6.3% | +31.8% | +9.8% |
| ROCEReturn on capital employed | -23.5% | +4.4% | — | +33.5% | +9.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 3 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.12x | 1.96x | — | 0.09x | 2.05x |
| Net DebtTotal debt minus cash | -$15M | $34.5B | $3M | -$1.9B | $53.5B |
| Cash & Equiv.Liquid assets | $19M | $5.0B | $20,000 | $2.9B | $13.6B |
| Total DebtShort + long-term debt | $5M | $39.5B | $3M | $962M | $67.2B |
| Interest CoverageEBIT ÷ Interest expense | -36.85x | 0.82x | -3.79x | 90.32x | 6.41x |
Total Returns (Dividends Reinvested)
SIFY leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBM five years ago would be worth $18,832 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +273.9% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors SIFY at 30.0% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.9% | +33.0% | -93.8% | -29.3% | -20.0% |
| 1-Year ReturnPast 12 months | +22.9% | +273.9% | -99.9% | -23.7% | -6.3% |
| 3-Year ReturnCumulative with dividends | -28.6% | +119.6% | -100.0% | -5.9% | +103.8% |
| 5-Year ReturnCumulative with dividends | -49.0% | -9.2% | -100.0% | -17.5% | +88.3% |
| 10-Year ReturnCumulative with dividends | -75.0% | +147.9% | -100.0% | +76.2% | +108.0% |
| CAGR (3Y)Annualised 3-year return | -10.6% | +30.0% | -96.0% | -2.0% | +26.8% |
Risk & Volatility
Evenly matched — SIFY and INFY each lead in 1 of 2 comparable metrics.
Risk & Volatility
INFY is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than HCTI's 3.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SIFY currently trades 91.5% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.87x | 1.35x | 3.25x | 0.86x | 1.00x |
| 52-Week HighHighest price in past year | $4.89 | $17.85 | $7410.00 | $30.00 | $324.90 |
| 52-Week LowLowest price in past year | $1.64 | $4.15 | $0.29 | $12.16 | $220.72 |
| % of 52W HighCurrent price vs 52-week peak | +45.0% | +91.5% | +0.0% | +42.8% | +70.7% |
| RSI (14)Momentum oscillator 0–100 | 51.5 | 61.2 | 35.4 | 40.2 | 43.9 |
| Avg Volume (50D)Average daily shares traded | 496K | 57K | 285K | 16.1M | 5.3M |
Analyst Outlook
Evenly matched — INFY and IBM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SIFY as "Buy", INFY as "Hold", IBM as "Hold". Consensus price targets imply 34.8% upside for IBM (target: $310) vs 31.7% for INFY (target: $17). For income investors, INFY offers the higher dividend yield at 4.54% vs IBM's 2.87%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | — | Hold | Hold |
| Price TargetConsensus 12-month target | — | — | — | $16.90 | $309.64 |
| # AnalystsCovering analysts | — | 1 | — | 40 | 50 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | — | +4.5% | +2.9% |
| Dividend StreakConsecutive years of raises | — | 0 | — | 4 | 30 |
| Dividend / ShareAnnual DPS | — | $0.36 | — | $0.58 | $6.59 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
INFY leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). SIFY leads in 1 (Total Returns). 2 tied.
AMPG vs SIFY vs HCTI vs INFY vs IBM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMPG or SIFY or HCTI or INFY or IBM a better buy right now?
For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.
9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Infosys Limited (INFY) offers the better valuation at 16. 9x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate Sify Technologies Limited (SIFY) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMPG or SIFY or HCTI or INFY or IBM?
On trailing P/E, Infosys Limited (INFY) is the cheapest at 16.
9x versus International Business Machines Corporation at 20. 6x. On forward P/E, Infosys Limited is actually cheaper at 16. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: International Business Machines Corporation wins at 1. 49x versus Infosys Limited's 2. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AMPG or SIFY or HCTI or INFY or IBM?
Over the past 5 years, International Business Machines Corporation (IBM) delivered a total return of +88.
3%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: SIFY returned +147. 9% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMPG or SIFY or HCTI or INFY or IBM?
By beta (market sensitivity over 5 years), Infosys Limited (INFY) is the lower-risk stock at 0.
86β versus Healthcare Triangle, Inc. 's 3. 25β — meaning HCTI is approximately 280% more volatile than INFY relative to the S&P 500. On balance sheet safety, Infosys Limited (INFY) carries a lower debt/equity ratio of 9% versus 2% for International Business Machines Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AMPG or SIFY or HCTI or INFY or IBM?
By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.
9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: International Business Machines Corporation grew EPS 73. 7% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, AMPG leads at 21. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMPG or SIFY or HCTI or INFY or IBM?
Infosys Limited (INFY) is the more profitable company, earning 16.
4% net margin versus -118. 2% for AmpliTech Group, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFY leads at 21. 1% versus -88. 7% for AMPG. At the gross margin level — before operating expenses — IBM leads at 59. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMPG or SIFY or HCTI or INFY or IBM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, International Business Machines Corporation (IBM) is the more undervalued stock at a PEG of 1. 49x versus Infosys Limited's 2. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Infosys Limited (INFY) trades at 16. 8x forward P/E versus 18. 5x for International Business Machines Corporation — 1. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IBM: 34. 8% to $309. 64.
08Which pays a better dividend — AMPG or SIFY or HCTI or INFY or IBM?
In this comparison, INFY (4.
5% yield), IBM (2. 9% yield) pay a dividend. AMPG, SIFY, HCTI do not pay a meaningful dividend and should not be held primarily for income.
09Is AMPG or SIFY or HCTI or INFY or IBM better for a retirement portfolio?
For long-horizon retirement investors, Infosys Limited (INFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), 4. 5% yield). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INFY: +76. 2%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMPG and SIFY and HCTI and INFY and IBM?
These companies operate in different sectors (AMPG (Technology) and SIFY (Communication Services) and HCTI (Healthcare) and INFY (Technology) and IBM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMPG is a small-cap quality compounder stock; SIFY is a small-cap quality compounder stock; HCTI is a small-cap quality compounder stock; INFY is a mid-cap deep-value stock; IBM is a large-cap quality compounder stock. INFY, IBM pay a dividend while AMPG, SIFY, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.